US approves first injectable drug to prevent HIV infection

Media/news company

Mwananchi Communications Limited

The caveat for its use, as imposed by the Food and Drug Administration, is that the user has to be HIV negative and weigh at least 35 kilogrammes.Before this approval, other forms of PrEP that were taken by HIV negative at-risk individuals were daily pills and so far, only two types of those— Truvada and Descovy— had been approved for use.“Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill,” said Debra Birnkrant, director of the Division of Antivirals in the FDA’s Center for Drug Evaluation and Research in a press statement.The approval of injectable PrEP is now available in the US and the Aids vaccine advocacy coalition (Avac) said in a statement shortly after its approval that Avac and partners would work to support the review by health regulatory authorities in other parts of the world.“With as few as six shots per year, this highly effective form of injectable PrEP can help bend the curve of the HIV epidemic – but only if its approval is accompanied by strategic, effective and equitable rollout that transforms the growing list of HIV prevention options into real and accessible choices for the people who need prevention most,” said Avac executive director Mitchell Warren.Kenya’s Health Ministry’s PrEP Programme Manager Mary Mugambi told the Nation that despite the drug being approved for use by US FDA, the country’s drug regulatory authority, the Pharmacy and Poisons Board, has to give it a nod as well before it is rolled out in the country.Research from clinical trials that were published last year showed better results from the injectable PrEP compared to the oral pills.A report published by the World Health Organisation in November last year that is based on a study conducted in south and eastern Africa, including Kenya, on women at risk of acquiring HIV showed bias on the injectable.

US approves first injectable drug to prevent HIV infection

Latest

Aziz KI sees red, but 10-man Yanga hold firm

Students’ loans board extends application deadline by four days due to network glitches

TFS turns to technology to strengthen management of 465 forest reserves

PM Nchemba orders contractors to speed up Simiyu power projects

Heche's defense testimony puts 2015 electoral integrity under the spotlight

Students in Tanzania develop technology to predict flood risks ahead of El Niño

In the headlines

Manufacturers seek lower ETS rates as tender comes to an end

How colonial-era law delays road compensation for crash victims

Tanzania universities Face AI test as future of jobs, learning takes centre stage

Businesses in Tanzania urged to build with Gen Z, not just market to them